Introduction
of LH and estradiol [6, 7, 15, 18, 19] , and to smaller degree on BMI and the levels of testosterone, androstendione, DHEAS, prolactin [20, 21] and progesterone [19] .
PR immunolocalization and immunoexpression in female ovaries still arouse great interest of researchers. This is mainly because of the diagnosis and treatment of infertility, safety of hormone therapy in the perimenopausal period, as well as influence on oncogenesis in a nipple, endometrium and ovary. In the ovaries of reproductive-age women, PR is observed in stromal and surface epithelial cells, in the early stages of follicular development, and in theca and granular cells [5, 7, 22, 23] . Its localization is also well known in corpus luteum [23, 24] . PR expression changes during menstrual cycle. Progesterone through PR modifies ovarian follicular development, inhibits FSH-induced estradiol synthesis and creation of receptors for LH, and as a consequence maturation of follicles. In preovulatory follicles it affects growth of a follicle and ovulation. Besides, it controls the development, functioning and regression of a corpus luteum [23, 24] .
The structure of a postmenopausal ovary significantly differs from that of reproductive-age. These differences are related to changes which concern both medulla and cortex. The division into these two structures becomes less distinct. Cortex loses its thickwalled character, the number of follicles reduces, and tendency to fragmentation of corpora albicantia can be observed. Epithelial inclusion cysts develop as a result of invagination of the surface epithelium and metaplasia of cuboidal epithelium. These cysts are usually present in ovarian stroma and surroundings of corpora albicantia. According to literature, 90% of epithelial ovarian carcinomas develops in such cysts or in the ovarian surface epithelium. Changes in medulla include fibrosis of the connective tissue, hyalinization of blood vessels, reduced blood vessel diameter, and altering blood vessel architecture [22, [25] [26] [27] [28] .
It is known that after menopause, ovaries are not replaced by hormonally inactive connective tissue. They produce about 50% of circulating in blood androgens, especially testosterone and androstendione, and also estrogens, however their number is much smaller than before menopause [29, 30] . On the contrary, it has not been examined yet, what is the dynamics of PR distribution during this period, or how it depends on the time from the last menstruation [30, 31] . Also the role which PRs play in an ovary after menopause is unknown. Hence, the aim of this study was to assess PR distribution and expression in the ovaries of postmenopausal women depending on the lapse of time from the last menstruation and to determine correlation of PR expression with concentrations of estradiol, testosterone, dehydroepiandrosterone, androstendione and gonadotropin in postmenopausal women.
Materials and methods
Patients. The study involved 50 postmenopausal women whose ovaries were removed by laparotomy because of non-neoplastic diseases of the uterus. None of them used substitutive hormone therapy before. The Bioethical Commission gave its consent for this study. All cases were diagnosed at the Department of Reproduction and Gynecology, Pomeranian Medical University, Szczecin. The women were divided into 3 groups depending on the time which passed from the last menstruation. Group A (25 patients) consisted of women who had the last menstruation no more than 5 years earlier. Group B was composed of women (15 patients) whose menopause appeared 5 to 10 years earlier. Group C (10 patients) included patients whose last menstruation was over 10 years earlier.
Hormone measurements. ELISA method enzyme immunoassay kit (Spi-Bio France) was used to measure concentrations of follicle stimulating hormone (FSH), luteinizing stimulating hormone (LH), estradiol (E 2 ), testosterone (T), androstendione (A) and dehydroepiandrosterone sulphate (DHEAS) in blood plasma in all the patients.
Morphology. Ovarian tissue (both cortex and medulla) was obtained during surgery. For morphological studies, ovaries were fixed in Bouin`s solution and 4% formalin, and embedded in paraffin. Sections were cut from the respective parts of ovaries. Morphological analysis was done after hematoxylin-eosin (H+E) staining.
Immunohistochemical quantification of progesterone receptor.
The paraffin-embedded specimens fixed in 4% buffered formalin were used for analysis of immunohistochemical expression of progesterone receptor PR. The slides were heated in citrate buffer, pH=9.0 for 30 min. in a water bath at 96°C. Next, the sections were incubated for 30 min. at the room temperature in humidified chamber with monoclonal mouse anti-human progesterone receptor antibody (N 1630 Dako, Denmark). The detection of anti-PR antibody was performed using Dako LSAB 2 KIT/HRP. Aminoethylocarbazole (AEC substrate chromogen) was applied to visualize the immunohistochemical reaction. Finally, the sections were counterstained with Mayer's hematoxylin. After each step, the sections were rinsed with Tris-buffered saline (TBS). The control sections were incubated with TBS instead of the primary antibody.
Statistical analysis. Statistical analysis was done by means of the Kruskal-Wallis test. p<0.05 was accepted as the significance level.
Results

Age of the examined patients
In group A the mean age of the patients was 46.3±1.2 (M±SD), in group B it was 52.4±3.8 (M±SD), and in group C -58.6±2.4 (M±SD). Considerable age differences were observed between women from groups: A and B, B and C, and A and C (p<0.05).
The levels of E 2 and FSH, LH, A, T, DHEAS in serum of the examined patients
The mean E 2 , FSH, LH, A, T, DHEAS serum concentrations of the examined patients are illustrated in Table 1 .
The mean E 2 serum concentrations did not significantly differ from each other groups, but the mean FSH and T serum concentrations significantly differ from each other between the examined groups of women (between groups A and B, B and C, and A and C) and LH, A, DHEAS serum concentrations significantly differ only between group A and C and B and C.
Morphology (H+E staining)
In the ovaries of postmenopausal women, the main structural changes in both the cortex and medulla were observed. In the cortex, they were: 1) the reduction of its thickness; 2) emergence of epithelial inclusion cysts; 3) the blurred line between medulla and cortex; 4) the increased follicle number; 5) the tendency to fragmentation of corpora albicantia; 6) surface epithelium invaginations. Changes in the medulla included: 1) fibrosis and scars in stroma; 2) architectonical changes in blood vessels with wall hyalinization and lumen constriction. In comparison to groups A and B, the ovaries of group C women contained small number of corpora albicantia located in the medullary part as well as thinned blood vessels and few lymphatic vessels and nerves. Our morphological results of the postmenopausal woman ovary (between groups A, B and C) have been already presented [24] .
Immunohistochemical results
PR immunohistochemical localization and immunoexpression in the ovaries of postmenopausal women were shown in Table 2 .
In our study, immunohistochemical nuclear expression of PR was revealed in OSE, epithelial inclusion cysts and stromal cells. Immunohistochemical nuclear expression of PR seems to be similar in the ovaries of women who are 5 and 10 years after menopause.
Discussion
The obtained research results seem to be very interesting. After menopause, localization of PR receptors was observed in the ovarian stromal cells, surface epithelium cells and inclusion cysts with metaplastic epithelium. What is more, expression of these receptors did not change depending on the lapse of time from menopause. The reasons for that are not known because in other tissues, ex. adipose tissue, immunoexpression and immunolocalization of PR decreased in women after their last menstruation [21] . It also is not known why our results did not reveal any correlation between the decreasing concentrations of T, A and DHEAS and increasing concentrations of FSH and LH, and PR expression in postmenopausal women. Such correlation was reported by other authors, but their research involved women at the reproductive age [7] . After menopause, PR expression was stronger in the skin of those women who had higher DHEAS concentration [21] .
A very important thing is the change in the ovarian structure after menopause, especially in the aspect of emergence of epithelial inclusion cysts lined with metaplastic epithelium. These cysts are the most common reason for ovarian cancer development [22] . The obtained results suggest that they contain PR and its expression does not change depending on the time which passed from menopause. The role of this receptor in postmenopausal women is not known. Undoubtedly, it was proved that PR immunoexpression intensifies the proliferation of ductal tubular cells, and thus Fig. 2 . Ovary of group C postmenopausal women (examined more than 10 years after menopause). Immunohistochemical localization of PR in some nuclei of ovarian surface epithelium (arrows) and in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 3 . Ovary of group A postmenopausal women (examined no more than 5 years after menopause). Immunohistochemical localization of PR. Strong nuclear staining is present in columnar epithelial cells (invaginations of ovarian surface epithelium metaplastic changes, epithelial inclusion cysts) (arrows). Nuclear expression of PR in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 4 . Ovary of group C postmenopausal women (examined more than 10 years after menopause). Strong nuclear expression of PR in the epithelial inclusion cyst (arrows) and in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×200). Fig. 5 . Ovary of group A postmenopausal women (examined no more than 5 years after menopause). Strong nuclear staining is present in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 6 . Ovary of group C postmenopausal women (examined more than 10 years after menopause). Strong nuclear staining is present in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). affects mammary cancer development [4, 10] . Recently, some articles have been published on the subject of an effect which PR activation have on ovarian cancer development. It was proven that especially PR-As strongly influence proliferation of ovarian epithelial cells [32] [33] [34] . These receptors are present in most cases of serous ovarian cancers [11, 12, 32] . It may explain an increase in the incidence of ovarian cancer observed in women using progestagen hormone therapy [21] . To sum up, on the basis of the conducted studies it can be said that in postmenopausal women ovaries, PRs are mainly located in ovarian stromal cells, surface epithelial cells and inclusion cysts with metaplastic epithelium, and expression of these receptors does not change depending on the lapse of time from menopause. Furthermore, PR expression in the ovaries of postmenopausal women does not correlate with T, A, DHEAS and gonadotropin concentrations in blood serum.
